Eisai Co. Ltd.

Pharmaceuticals
Japan
Earnings Per Share Growth (%)26.68%
Cost of Goods Sold (US$ Millions)$1,615
Current Liabilities (US$ Millions)$1,285
Total Assets (US$ Millions)$3,720
Long Term Debt$0
Return on Equity9.17%
Revenue (US$ Millions)$4,552
Total Company Assets$8,091
Revenue Growth (%)-0.10%
Net Income (US$ Millions)$456
Earnings Per Share (US$)$26.68
Total Equity (US$ Millions)$4,765
Profit Margin (%)10.03%
Debt To Equity Ratio (%)0.00%
Inventory Turnover$612